L-Carnitine for the treatment of highly active antiretroviral therapy-related hypertriglyceridemia in HIV-infected adults

AIDS. 2001 Jun 15;15(9):1194-5. doi: 10.1097/00002030-200106150-00024.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antiretroviral Therapy, Highly Active / adverse effects
  • Blood Glucose / analysis
  • Carnitine / administration & dosage
  • Carnitine / therapeutic use*
  • Cholesterol / blood
  • Female
  • HIV Infections / blood
  • HIV Infections / complications*
  • HIV Infections / virology
  • Humans
  • Hypertriglyceridemia / blood
  • Hypertriglyceridemia / chemically induced
  • Hypertriglyceridemia / drug therapy*
  • Hypertriglyceridemia / virology
  • Male
  • Pilot Projects
  • Prospective Studies
  • RNA, Viral / blood
  • Treatment Outcome
  • Triglycerides / blood
  • Viral Load

Substances

  • Blood Glucose
  • RNA, Viral
  • Triglycerides
  • Cholesterol
  • Carnitine